Three important amendments to an appropriations bill related to DEA funding were passed by the House today, two regarding Hemp and one regarding crackdowns on the Federal level on legal Medical Marijuana businesses and patients in states that have Medical Marijuana programs in place.
The Hemp amendments will prevent the DEA from interfering with state run Hemp programs, and come on the heals of the recent seizure by the DEA of some 250 lbs. of Hemp seed that were being imported into Kentucky’s pilot program last month. These Hemp programs will be important in the early sourcing of substances like CBD (Cannabidiol) that are currently more difficult – in regards to federal law – to prepare extracts and tinctures from, with low THC Hemp offering a ready and viable source for high CBD oils.
The Medical Marijuana amendment is meant to prevent the DEA from using funding to prosecute patients and businesses in states that have approved Medical Marijuana programs. While the amendment is tied up in appropriations, it sends a clear message about the changing tone in the country regarding the topics of both Medical Marijuana and Hemp laws, and the Medical Marijuana amendment passed by an impressive margin, with bipartisan support.
Votes like these continue to erode away at the DEA and NIDA stance of “no acceptable medical use” regarding Cannabis. 22 states have passed MedMJ laws, and five now have passed CBD laws and widespread support like this will eventually force the issue of the impending reclassification of Cannabis as a Schedule one drug, as that is the crux of the problem. Reclassification of Cannabis to reflect its true medicinal status will help alleviate many of the issues currently surrounding incarceration and research.